SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-19-010707
Filing Date
2019-09-27
Accepted
2019-09-27 17:13:40
Documents
2
Period of Report
2019-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1684
2 ex24onetto.txt EX-24 3510
  Complete submission text file 0001179110-19-010707.txt   6670
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 58 S SERVICE RD MELVILLE NY 11747
Business Address
ONETTO NICOLE (Reporting) CIK: 0001220049 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 191122920